![Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities | Nature Reviews Rheumatology Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities | Nature Reviews Rheumatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41584-021-00657-4/MediaObjects/41584_2021_657_Fig1_HTML.png)
Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities | Nature Reviews Rheumatology
![JCM | Free Full-Text | Risk of Acute Myocardial Infarction Among New Users of Allopurinol According to Serum Urate Level: A Nested Case-Control Study JCM | Free Full-Text | Risk of Acute Myocardial Infarction Among New Users of Allopurinol According to Serum Urate Level: A Nested Case-Control Study](https://www.mdpi.com/jcm/jcm-08-02150/article_deploy/html/images/jcm-08-02150-g002.png)
JCM | Free Full-Text | Risk of Acute Myocardial Infarction Among New Users of Allopurinol According to Serum Urate Level: A Nested Case-Control Study
![Antioxidants | Free Full-Text | Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD Antioxidants | Free Full-Text | Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD](https://pub.mdpi-res.com/antioxidants/antioxidants-11-01297/article_deploy/html/images/antioxidants-11-01297-g001.png?1656502321)
Antioxidants | Free Full-Text | Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
![Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial - The Lancet Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial - The Lancet](https://www.thelancet.com/cms/asset/564076c6-611f-4087-9fb1-dd87fa7f1e38/gr1.jpg)
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial - The Lancet
![Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial - The Lancet Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial - The Lancet](https://www.thelancet.com/cms/attachment/2001011132/2003795326/gr1.gif)
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial - The Lancet
![Optimizing adherence to allopurinol for gout: patients' perspectives - Spragg - British Journal of Clinical Pharmacology - Wiley Online Library Optimizing adherence to allopurinol for gout: patients' perspectives - Spragg - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/a67ef12d-d3c1-4df1-ba9b-22cacaa4b66e/bcp15657-fig-0002-m.jpg)
Optimizing adherence to allopurinol for gout: patients' perspectives - Spragg - British Journal of Clinical Pharmacology - Wiley Online Library
![A drug that does exactly what it says on the tin — the story of allopurinol - The Pharmaceutical Journal A drug that does exactly what it says on the tin — the story of allopurinol - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/03/Screen-Shot-2021-03-18-at-16.52.54.png)
A drug that does exactly what it says on the tin — the story of allopurinol - The Pharmaceutical Journal
![The teratogenicity of allopurinol: A comprehensive review of animal and human studies - ScienceDirect The teratogenicity of allopurinol: A comprehensive review of animal and human studies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0890623818301904-gr1.jpg)